These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33878211)

  • 1. Reply to letter to editor "Cancer patients should be considered as a high-risk priority target in the COVID-19 vaccination process".
    Rajan S; Akhtar N; Kumar V; Gupta S; Chaturvedi A; Sharma S
    J Surg Oncol; 2021 Sep; 124(3):455. PubMed ID: 33878211
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
    Kamura Y; Matsue K
    Int J Infect Dis; 2022 Sep; 122():1005. PubMed ID: 35760377
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to a Letter to the Editor on a Published Manuscript: Bilateral Multifocal Choroiditis following COVID-19 Vaccination.
    Goyal M; Murthy SI
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1211. PubMed ID: 34524951
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to letter to the editor "antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment".
    Narita D; Ebina-Shibuya R
    Respir Investig; 2023 May; 61(3):347-348. PubMed ID: 36947984
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
    Mayo S; Monfort S
    J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119-20.
    Finsterer J; Stollberger C
    Heart Lung Circ; 2022 May; 31(5):e76-e77. PubMed ID: 35063380
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor: Financial incentives for COVID-19 vaccination.
    Kim HB
    Epidemiol Health; 2021; 43():e2021088. PubMed ID: 34781635
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to the letter entitled: Re: The first report on Covid-19 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey.
    Di Noia V; Riva F; Di Civita M; Cosimati A; Cognetti F
    Eur J Cancer; 2021 Nov; 158():253-254. PubMed ID: 34663560
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the letter to the editor: "impact of SARS-CoV-2 vaccines on the nervous system".
    Corrêa DG; Hygino da Cruz LC
    Clin Imaging; 2022 Feb; 82():5-6. PubMed ID: 34763264
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination.
    Finsterer J; Scorza FA
    J Korean Med Sci; 2021 Oct; 36(40):e288. PubMed ID: 34664806
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.
    Finsterer J
    J Korean Med Sci; 2022 Jul; 37(26):e217. PubMed ID: 35790211
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the editor: "Autoimmune hepatitis after COVID-19 vaccination".
    Mungmunpuntipantip R; Wiwanitkit V
    Hepatology; 2022 Mar; 75(3):756. PubMed ID: 34797931
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination.
    Cao Z; Gui H; Sheng Z; Xin H; Xie Q
    Hepatology; 2022 Mar; 75(3):757-759. PubMed ID: 34862637
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: Need for population-based epidemiological study.
    Suzuki Y; Kakisaka K; Takikawa Y
    Hepatology; 2022 Mar; 75(3):759-760. PubMed ID: 34904265
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
    Rajan S; Akhtar N; Sharma S; Chakrabarti D; Kumar V
    Vaccine; 2021 Aug; 39(36):5075-5077. PubMed ID: 34340859
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 vaccination in pediatric cancer patients: A high priority.
    Charla Y; Kalra M; Chopra N; Choudhury S
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29397. PubMed ID: 34636133
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims.
    Choi YJ
    Epidemiol Health; 2021; 43():e2021087. PubMed ID: 34781634
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?
    Lo GH
    Hepatology; 2023 Feb; 77(2):E32. PubMed ID: 36053792
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to editor, in response to paper entitled "Side effects after COVID-19 vaccinations among residents of Poland".
    Nugraha Putra O; Nur Hidayatullah AY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5579-5580. PubMed ID: 34604949
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.
    Body A; Ahern E; Segelov E
    Intern Med J; 2021 Oct; 51(10):1760. PubMed ID: 34664360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.